RAPP
Ticker
Rapport Therapeutics, Inc.
RAPP · Healthcare · Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transfo…Rapport Therapeutics, Inc. (RAPP), in the Healthcare sector, has 25 disclosed filings on Paydirt over the trailing twelve months from 6 corporate insiders: 0 purchases and 25 sales. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Sep 8 and filed Sep 9. The most active filer was David Bredt with 9 filings.
Add to watchlistFilings, ttm
25
0 buys · 25 sells
Traders, ttm
6
6 insiders
Volume, ttmiDollar value disclosed in the window
$45.4M
estimated for Congress, as filed for insiders
Median delay
1d
execution to disclosure
Last traded
Sep 8
Filed Sep 9
ADViAverage daily dollar volume
$17.2M
market data
Share price · 12M
$42.68 (+63.5%)
Adjusted for splits and dividends.
Volume by month
Buys $1.5M
Sells $47.9M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
DBRecent filings
Abraham CeesaySALE
Chief Executive Officer
$325K7,141 sh × $45.55
Exec Sep 8
Filed Sep 9 · 4:05 PM ET Abraham CeesaySALE Chief Executive Officer $938K
18,921 sh × $49.57
Exec Aug 25
Filed Aug 26 · 4:05 PM ET Krishnaswamy YeleswaramSALE Chief Development Officer $2.5M
50,160 sh across 3 lots
Exec Aug 24
Filed Aug 26 · 4:00 PM ET Abraham CeesaySALE Chief Executive Officer $2.4M
51,499 sh across 5 lots
Exec Aug 10
Filed Aug 12 · 4:35 PM ET Abraham CeesaySALE Chief Executive Officer $328K
8,210 sh across 2 lots
Exec Jul 14
Filed Jul 15 · 4:15 PM ET Cheryl GaultSALE Chief Operating Officer $296K
7,100 sh across 2 lots
Exec Jun 30
Filed Jul 1 · 4:10 PM ET Abraham CeesaySALE Chief Executive Officer $292K
7,344 sh × $39.77
Exec Jun 29
Filed Jul 1 · 4:05 PM ET Third Rock Ventures V, L.P.SALE 10% owner $744K
18,572 sh × $40.05
Exec May 26
Filed May 28 · 5:30 PM ET Third Rock Ventures V, L.P.SALE 10% owner $5.4M
133,618 sh × $40.24
Exec May 11
Filed May 13 · 5:30 PM ET Third Rock Ventures VI, L.P.SALE 10% owner $11.1M
276,513 sh across 2 lots
Exec May 7
Filed May 11 · 5:30 PM ET Krishnaswamy YeleswaramSALE Chief Development Officer $809K
20,225 sh × $39.99
Exec Apr 17
Filed Apr 21 · 5:30 PM ET Third Rock Ventures VI, L.P.SALE 10% owner $17.2M
426,005 sh × $40.32
Exec Apr 17
Filed Apr 21 · 5:30 PM ET Krishnaswamy YeleswaramSALE Chief Development Officer $678K
19,365 sh across 2 lots
Exec Apr 13
Filed Apr 14 · 5:30 PM ET Cheryl GaultSALE Chief Operating Officer $201K
7,161 sh × $28.04
Exec Mar 30
Filed Mar 31 · 5:30 PM ET Krishnaswamy YeleswaramSALE Chief Development Officer $303K
10,115 sh × $29.99
Exec Mar 25
Filed Mar 26 · 5:30 PM ET David BredtSALE Chief Scientific Officer $156K
5,400 sh × $28.95
Exec Feb 17
Filed Feb 19 · 5:30 PM ET Abraham CeesaySALE Chief Executive Officer $103K
3,552 sh × $29.05
Exec Feb 18
Filed Feb 19 · 5:30 PM ET Abraham CeesaySALE Chief Executive Officer $285K
10,916 sh across 2 lots
Exec Jan 20
Filed Jan 22 · 5:30 PM ET David BredtSALE Chief Scientific Officer $223K
8,300 sh × $26.83
Exec Jan 15
Filed Jan 16 · 5:30 PM ET David BredtSALE Chief Scientific Officer $197K
6,567 sh × $30.05
Exec Dec 31 2025
Filed Jan 5 · 5:30 PM ET David BredtSALE Chief Scientific Officer $231K
7,704 sh × $29.95
Exec Dec 15 2025
Filed Dec 16 2025 · 5:30 PM ET Cheryl GaultSALE Chief Operating Officer $150K
5,000 sh × $30.10
Exec Nov 26 2025
Filed Dec 1 2025 · 5:30 PM ET David BredtSALE Chief Scientific Officer $136K
5,344 sh × $25.39
Exec Nov 17 2025
Filed Nov 18 2025 · 5:30 PM ET Abraham CeesaySALE Chief Executive Officer $231K
8,975 sh across 2 lots
Exec Oct 15 2025
Filed Oct 16 2025 · 5:30 PM ET David BredtSALE Chief Scientific Officer $191K
7,418 sh × $25.73
Exec Oct 15 2025
Filed Oct 16 2025 · 5:30 PM ET